UNSPSC 51183406: Mitiglinide calcium dihydrate

This classification denotes an anti-diabetic agent 2C19H24NO3.Ca.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9651C21W3Z, chemically known as bis((2s)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionate) calcium dihydrate, d-, but more generally known as mitiglinide calcium dihydrate, which bears US NIH Compound Identifier 6918235. European Medicines Agency schedules Mitiglinide calcium dihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21788.

UNSPSC 51183406 Mitiglinide calcium dihydrate is a Commodity code for a pharmaceutical active ingredient used in diabetes management that state and local procurement offices rarely encounter as a standalone purchase line. State and local governments do not typically procure raw pharmaceutical compounds; instead, they buy finished medications through group purchasing organizations, pharmacy benefit managers, and direct state Medicaid contracts. When this code appears in state and local solicitations, it reflects either a data-entry error in the tagging system or an atypical procurement—such as a research institution or state health laboratory acquiring the substance for analytical or compounding purposes.

The source provides no recent state and local contract opportunities tagged to this code. Without active solicitation records, no characterization of issuing bodies, geographic concentration, or representative recent work is possible. Business development professionals should treat this code as inactive in the state and local market and focus procurement strategy on higher-tier family codes related to pharmaceutical products and services (such as finished-goods pharmacy sourcing or Medicaid-managed-care services procurement) where state agencies and school districts regularly issue volume opportunities.